Looking forward lung metastasectomy—do we need a staging system for lung metastases?

Gonzalez, Michel

doi:10.21037/atm.2016.03.15

Cited by 7 publications

(4 citation statements)

References 23 publications

(20 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…M. Migliore then moved on to discuss the heterogeneity seen in this patient population, with patient, disease and treatment factors interacting to determine outcome; and to propose a recently updated concept of a dedicated staging system for pulmonary metastasis (pmTNM) [ 18 , 19 ]. This considers the complex interaction between lesion number, nodal involvement and extra-thoracic disease, and aims to present stage-grouping to help inform decision making for local treatment according to a traffic-light system.…”

Section: Group 81mentioning

confidence: 99%

“…This proposes that patients with designated Stage 1 or 2 (Green) disease (up to three lesions in both lungs, or more than three lesions restricted to a single lung, but with no lymph node involvement or extra-thoracic disease) should be considered for metastasectomy, while patients at pmTNM Stage 4 (Red) (more than three lesions with a bilateral distribution, any intrathoracic lymph node involvement contralateral to unilateral pulmonary lesions, and involvement of more than one extra-thoracic site) should be excluded from local therapies. Stage 3 (Orange) represents an intermediate group where a cautious indication may exist [ 18 , 19 ]. Although preliminary successful validation has been reported at the meeting on a retrospective cohort of 264 patients, this approach is being validated in a larger group of patients [ 20 ].…”

Section: Group 81mentioning

confidence: 99%

See 1 more Smart Citation

ERS International Congress 2021: highlights from the Thoracic Surgery and Lung Transplantation Assembly

et al. 2022

Self Cite

View full text Add to dashboard Cite

The thoracic surgery and lung transplantation assembly of the European Respiratory Society (ERS) is delighted to present the highlights from the 2021 International ERS Congress. We have selected four sessions that discussed recent advances across a wide range of topics: including digital health surveillance in thoracic surgery, emerging concepts in pulmonary metastasectomy, advances in mesothelioma care, and novel developments in lung graft allocation and monitoring. The sessions are summarised by early career members in close collaboration with the assembly faculty. We aim to give the reader an update on the highlights of the conference in the fields of thoracic surgery and lung transplantation.

show abstract

Section: Group 81mentioning

confidence: 99%

Section: Group 81mentioning

confidence: 99%

ERS International Congress 2021: highlights from the Thoracic Surgery and Lung Transplantation Assembly

et al. 2022

Self Cite

View full text Add to dashboard Cite

show abstract

“…The TNM classification of tumors is evolving continuously and interested specialists ask for further modifications based on innovations obtained by powerful prospective studies (14,15). For example, I proposed a dedicated staging system for lung metastases (16,17). It relies on the number of metastases and location of lymph nodes involved.…”

Section: Dedicated Tnm Classification For Ggosmentioning

confidence: 99%

Ground glass opacities of the lung before, during and post COVID-19 pandemic

Migliore

2021

Ann Transl Med

Self Cite

View full text Add to dashboard Cite

“…Of course, such a framework is tentative at best and needs to be supported by more studies, but the trend towards more evidence-based personalized surgery will without a doubt highly benefit patients. A specific TNM classification for PMs could be an adjunct to better characterize the profile of the metastatic patients and simplify the decision algorithm (25). In both instances, this promises exciting improvements in surgical management of PMs.…”

Section: Perspectivementioning

confidence: 99%